Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephanie E Weissinger

Showing results (1-10 of 25) with videos related to

Pageof 3
Sort By:
International Journal of Surgical Pathology|December 1, 2016
Performance Testing of RREB1, MYB, and CCND1 Fluorescence In Situ Hybridization in Spindle-Cell and Desmoplastic Melanoma Argues for a Two-Step Test AlgorithmStephanie E Weissinger, Manfred Frick, Peter Möller, et al.
European Journal of Haematology|December 2, 2021
Combination of two monoclonal antibodies with SOCS1 N- and C-terminal binding sites to address SOCS1 status in B cells and B-cell lymphomaStephanie E Weissinger, Malena Zahn, Ralf Marienfeld, et al.
European Journal of Haematology|March 13, 2021
A new reliable and highly specific monoclonal antibody to detect the C-terminal region of silencer of cytokine signaling 1Stephanie E Weissinger, Malena Zahn, Ralf Marienfeld, et al.
Cancers|September 28, 2019
FOXO1 Confers Maintenance of the Dark Zone Proliferation and Survival Program and Can Be Pharmacologically Targeted in Burkitt LymphomaFranziska Gehringer, Stephanie E Weissinger, Lotteke Jym Swier, et al.
Journal of Pathology Informatics|November 8, 2014
A nuclear circularity-based classifier for diagnostic distinction of desmoplastic from spindle cell melanoma in digitized histological imagesManuel Schöchlin, Stephanie E Weissinger, Arnd R Brandes, et al.
Oncotarget|January 18, 2015
GOT1/AST1 expression status as a prognostic biomarker in pancreatic ductal adenocarcinomaFenja M Feld, Philipp D Nagel, Stephanie E Weissinger, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|September 21, 2013
A diagnostic algorithm to distinguish desmoplastic from spindle cell melanomaStephanie E Weissinger, Philipp Keil, David N Silvers, et al.
European Journal of Dermatology : EJD|February 9, 2017
Checkpoint inhibition for advanced mucosal melanomaJulia Thierauf, Johannes A Veit, Jochen Hess, et al.
Ejhaem|September 2, 2022
Targetable alterations in primary extranodal diffuse large B-cell lymphomaStephanie E Weissinger, Rucha Dugge, Miriam Disch, et al.
Laryngo- Rhino- Otologie|January 4, 2021
[Primary small cell neuroendocrine carcinoma of the larynx: a review of literature and case series]Felix Böhm, Patrick J Schuler, Johannes Döscher, et al.
Pageof 3

Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
International Journal of Surgical Pathology|December 1, 2016
Performance Testing of RREB1, MYB, and CCND1 Fluorescence In Situ Hybridization in Spindle-Cell and Desmoplastic Melanoma Argues for a Two-Step Test AlgorithmStephanie E Weissinger, Manfred Frick, Peter Möller, et al.
European Journal of Haematology|December 2, 2021
Combination of two monoclonal antibodies with SOCS1 N- and C-terminal binding sites to address SOCS1 status in B cells and B-cell lymphomaStephanie E Weissinger, Malena Zahn, Ralf Marienfeld, et al.
European Journal of Haematology|March 13, 2021
A new reliable and highly specific monoclonal antibody to detect the C-terminal region of silencer of cytokine signaling 1Stephanie E Weissinger, Malena Zahn, Ralf Marienfeld, et al.
Cancers|September 28, 2019
FOXO1 Confers Maintenance of the Dark Zone Proliferation and Survival Program and Can Be Pharmacologically Targeted in Burkitt LymphomaFranziska Gehringer, Stephanie E Weissinger, Lotteke Jym Swier, et al.
Journal of Pathology Informatics|November 8, 2014
A nuclear circularity-based classifier for diagnostic distinction of desmoplastic from spindle cell melanoma in digitized histological imagesManuel Schöchlin, Stephanie E Weissinger, Arnd R Brandes, et al.
Oncotarget|January 18, 2015
GOT1/AST1 expression status as a prognostic biomarker in pancreatic ductal adenocarcinomaFenja M Feld, Philipp D Nagel, Stephanie E Weissinger, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|September 21, 2013
A diagnostic algorithm to distinguish desmoplastic from spindle cell melanomaStephanie E Weissinger, Philipp Keil, David N Silvers, et al.
European Journal of Dermatology : EJD|February 9, 2017
Checkpoint inhibition for advanced mucosal melanomaJulia Thierauf, Johannes A Veit, Jochen Hess, et al.
Ejhaem|September 2, 2022
Targetable alterations in primary extranodal diffuse large B-cell lymphomaStephanie E Weissinger, Rucha Dugge, Miriam Disch, et al.
Laryngo- Rhino- Otologie|January 4, 2021
[Primary small cell neuroendocrine carcinoma of the larynx: a review of literature and case series]Felix Böhm, Patrick J Schuler, Johannes Döscher, et al.
Pageof 3